Pacific Biosciences of California, Inc. designs, develops, manufactures, and markets an integrated platform for genetic analysis. The company provides single molecule real-time (SMRT) technology platform, which enables single molecule real-time detection of biological processes. It offers PacBio RS II high resolution genetic analyzer, an instrument that conducts, monitors, and analyzes single molecule biochemical reactions in real time. The company provides consumable products, which include sealed and packaged SMRT Cells, as well as various reagent kits, such as template preparation kits, binding kits, and sequencing kits to run the PacBio RS II. Its customers include research institutions,...
1380 Willow Road
Menlo Park, CA 94025
Founded in 2000
Pacific Biosciences of California, Inc. Announces Unaudited Consolidated Earnings Results for the Fourth Quarter and Year Ended December 31, 2015
Feb 3 16
Pacific Biosciences of California, Inc. announced unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2015. For the quarter, the company's total revenue was $36,281,000, compared to $16,904,000 a year ago. Net loss was $1,409,000 compared with $18,975,000 or a year ago. Net loss per basic and diluted share was $0.02 per share as compared $0.26 a year ago. Operating loss was $1,062,000 compared with $17,894,000 a year ago.
For the year, the company's total revenue was $92,782,000 compared with $60,594,000 a year ago. Operating loss was $29,134,000 compared with operating loss of $62,854,000 a year ago. Net loss was $31,696,000 or $0.42 basic and diluted per share compared to $66,160,000 or $0.94 basic and diluted per share a year ago.
Roche Holding Reportedly Seeks To Acquire PACB
Feb 2 16
Roche Holding AG (SWX:ROG) has in recent weeks approached Pacific Biosciences of California, Inc. (NasdaqGS:PACB) to discuss acquiring the U.S. company, spurred by interest in its advanced gene-sequencing technology, people familiar with the matter said. Talks between the two companies have not yet advanced because of disagreements over the price of a potential deal, the people said this week. There is no certainty that Roche will continue to pursue Pacific Biosciences, the people added. The sources asked not to be identified because the discussions have not been public. Roche declined to comment, while Pacific Biosciences did not respond to requests for comment.
Pacific Biosciences of California, Inc. to Report Q4, 2015 Results on Feb 03, 2016
Jan 22 16
Pacific Biosciences of California, Inc. announced that they will report Q4, 2015 results on Feb 03, 2016